Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: A predictor of long-term mortality in HIV infection

Journal of Infectious Diseases

Volumn 176, Issue 3, 1997, Pages 798-800

  Craib, Kevin J P ^b   Strathdee, Steffanie A ^b   Hogg, Robert S ^b   Leung, Barbara ^b   Montaner, Julio S G ^b   O'Shaughnessy, Michael V ^b   Schechter, Martin T ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; HELPER CELL; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SEROCONVERSION;

EID: 0030853007     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517305     Document Type: Article

References (10)

1. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
2. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
3. Saksela K, Stevens CE, Rubinstein P, Taylor PE, Baltimore D. HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS. Ann Intern Med 1995;123:641-8.
4. O'Brien TR, Blattner WA, Waters D, et al. Serum HIV-1 RNA levels and time to development of AIDS in the Multicenter Hemophilia Cohort Study. JAMA 1996;276:105-10.
5. + lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996;334:426-31.
6. Schechter MT, Craib KJP, Le TN, et al. Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men. AIDS 1989;3:347-53.
7. Ho DD. Viral counts count in HIV infection. Science 1996;272:1124-5.
8. Ho DD. Editorial: time to hit HIV, early and hard. N Engl J Med 1995;334:450-1.
9. Kinloch-de Loës S, Hirschel BJ, Hoen B, et al. A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995;333:408-13.
10. Markowitz M, Cao Y, Hurley A, et al. Triple therapy with AZT, 3TC, and ritonavir in 12 subjects newly infected with HIV-1 [abstract Th.B.933]. In: Program and abstracts: XI International Conference on AIDS (Vancouver, Canada). Vancouver: XI International Conference on AIDS Society, 1996.